Oxaliplatin-resistant colorectal cancer models for nanoparticle hyperthermia

References

• Holch J, Stintzing S, Heinemann V. Treatment of metastatic colorectal cancer: standard of care and future perspectives. Visc Med. 2016;32(3):178–183.
   PubMed Web of Science ®Google Scholar
• Howlader NNA., Krapcho M, Miller D, et al. (eds.). SEER cancer statistics review. Bethesda (MD): National Cancer Institute; 2020.
   Google Scholar
• Goldberg RM, Rothenberg ML, Van Cutsem E, et al. The continuum of care: a paradigm for the management of metastatic colorectal cancer. Oncologist. 2007;12(1):38–50.
   PubMed Web of Science ®Google Scholar
• Sugarbaker P. Management of peritoneal-surface malignancy: the surgeon’s role. Langenbecks Arch Surg. 1999;384(6):576–587.
   PubMed Web of Science ®Google Scholar
• Glehen O, Cotte E, Kusamura S, et al. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion. J Surg Oncol. 2008;98(4):242–246.
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol/Hematol. 2002;43(1):33–56.
   PubMed Web of Science ®Google Scholar
• Issels RD. Hyperthermia adds to chemotherapy. Eur J Cancer. 2008;44(17):2546–2554.
   PubMed Web of Science ®Google Scholar
• Levine EA, Stewart IV, Shen JH, et al. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218(4):573–585.
   PubMed Web of Science ®Google Scholar
• Graham J, Mushin M, Kirkpatrick P. Oxaliplatin. Nat Rev Drug Discov. 2004;3(1):11–12.
   PubMed Web of Science ®Google Scholar
• Zhang X-L, Hu A-B, Cui S-Z, et al. Thermotherapy enhances oxaliplatin-induced cytotoxicity in human colon carcinoma cells. World J Gastroenterol. 2012;18(7):646.
   PubMed Web of Science ®Google Scholar
• Quenet F, Elias D, Roca L, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol. 2018;36(18)
   Web of Science ®Google Scholar
• Ceelen W. HIPEC with oxaliplatin for colorectal peritoneal metastasis: the end of the road? Eur J Surg Oncol. 2019;45(3):400–402.
   PubMed Web of Science ®Google Scholar
• Van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230–240.
   PubMed Web of Science ®Google Scholar
• Brouquet A, Goéré D, Lefèvre JH, et al. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome. Ann Surg Oncol. 2009;16(10):2744–2751.
   PubMed Web of Science ®Google Scholar
• Martinez-Balibrea E, Martínez-Cardús A, Ginés A, et al. Tumor-related molecular mechanisms of oxaliplatin resistance. Mol Cancer Ther. 2015;14(8):1767–1776.
   PubMed Web of Science ®Google Scholar
• Alzahrani NA, Valle SJ, Fisher OM, et al. Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a multi‐institutional experience. J Surg Oncol. 2018;119(3):336–346.
   PubMed Web of Science ®Google Scholar
• Mogal H, Chouliaras K, Levine EA, et al. Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes. J Gastrointest Oncol. 2016;7(1):129–142.
   PubMed Web of Science ®Google Scholar
• Graham EG, Macneill CM, Levi-Polyachenko NH. Review of metal, carbon and polymer nanoparticles for infrared photothermal therapy. Nano Life. 2013;03(03):1330002.
   Google Scholar
• Levi-Polyachenko NH, Stewart I, John H. Clinical relevance of nanoparticle induced hyperthermia for drug delivery and treatment of abdominal cancers. The Open Nanomed Nanotechnol J. 2011;3(1):24–37.
   Google Scholar
• Kobayashi T. Cancer hyperthermia using magnetic nanoparticles. Biotechnol J. 2011;6(11):1342–1347.
   PubMed Web of Science ®Google Scholar
• Burke AR, Singh RN, Carroll DL, et al. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials. 2012;33(10):2961–2970.
   PubMed Web of Science ®Google Scholar
• Levi-Polyachenko NH, Merkel EJ, Jones BT, et al. Rapid photothermal intracellular drug delivery using multiwalled carbon nanotubes. Mol Pharm. 2009;6(4):1092–1099.
   PubMed Web of Science ®Google Scholar
• Graham-Gurysh E, Kelkar S, McCabe-Lankford E, et al. Hybrid donor-acceptor polymer particles with amplified energy transfer for detection and on-demand treatment of breast cancer. ACS Appl Mater Interfaces. 2018;10(9):7697–7703.
   PubMed Web of Science ®Google Scholar
• Tian Z, Yu J, Wu C, et al. Amplified energy transfer in conjugated polymer nanoparticle tags and sensors. Nanoscale. 2010;2(10):1999–2011.
   PubMed Web of Science ®Google Scholar
• Engelmann UM, Roeth AA, Eberbeck D, et al. Combining bulk temperature and nanoheating enables advanced magnetic fluid hyperthermia efficacy on pancreatic tumor cells. Sci Rep. 2018;8(1):13210.
   PubMed Web of Science ®Google Scholar
• Qin Z, Etheridge M, Bischof JC. Nanoparticle heating: nanoscale to bulk effects of electromagnetically heated iron oxide and gold for biomedical applications. Paper presented at the SPIE BiOS conference; 2011 January 22–27; San Fransisco, CA.
   Google Scholar
• Bischof JC. Micro and nanoscale phenomenon in bioheat transfer. Heat Mass Transfer. 2006;42(10):955–966.
   Web of Science ®Google Scholar
• Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiati Oncol Biol Phys. 1984;10(6):787–800.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Viglianti B, Lora-Michiels M, et al. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia. 2003;19(3):267–294.
   PubMed Web of Science ®Google Scholar
• Hoopes PJ, Petryk AA, Giustini AJ, et al. Nanoparticle based cancer treatment: can delivered dose and biological dose be reliably modeled and quantified? Proc SPIE–the Int Soc Optic Eng. February 23rd, 2011: 79010A.
   Google Scholar
• Tarapacki C, Karshafian R. Enhancing laser therapy using PEGylated gold nanoparticles combined with ultrasound and microbubbles. Ultrasonics. 2015;57:36–43.
   PubMed Web of Science ®Google Scholar
• Pearce JA. Comparative analysis of mathematical models of cell death and thermal damage processes. Int J Hyperthermia. 2013;29(4):262–280.
   PubMed Web of Science ®Google Scholar
• Raoof M, Zhu C, Kaluarachchi WD, et al. Luciferase-based protein denaturation assay for quantification of radiofrequency field-induced targeted hyperthermia: developing an intracellular thermometer. Int J Hyperthermia. 2012;28(3):202–209.
   PubMed Web of Science ®Google Scholar
• Ubink I, Bolhaqueiro A, Elias S, et al. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy. Br J Surg. 2019;106(10):1404–1414.
   PubMed Web of Science ®Google Scholar
• Jensen NF, Stenvang J, Beck MK, et al. Establishment and characterization of models of chemotherapy resistance in colorectal cancer: towards a predictive signature of chemoresistance. Mol Oncol. 2015;9(6):1169–1185.
   PubMed Web of Science ®Google Scholar
• Yan X-D, Li M, Yuan Y, et al. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations. Oncol Rep. 2007;17(5):1163–1169.
   PubMed Web of Science ®Google Scholar
• Barr MP, Gray SG, Hoffmann AC, et al. Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature. PLoS One. 2013;8(1):e54193.
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Castanares M, Hedayati M, et al. Monitoring nanoparticle-mediated cellular hyperthermia with a high-sensitivity biosensor. Nanomedicine. 2014;9(18):2729–2743.
   PubMed Web of Science ®Google Scholar
• Roper DK, Ahn W, Hoepfner M. Microscale Heat Transfer Transduced by Surface Plasmon Resonant Gold Nanoparticles. J Phys Chem C. 2007;111(9):3636–3641.
   PubMed Web of Science ®Google Scholar
• Andrews PA, Murphy MP, Howell SB. Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells. Eur J Cancer Clin Oncol. 1989;25(4):619–625.
   PubMedGoogle Scholar
• Boyer J, McLean EG, Aroori S, et al. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan. Clin Cancer Res. 2004;10(6):2158–2167.
   PubMed Web of Science ®Google Scholar
• McCabe‐Lankford EE, Brown TL, Levi‐Polyachenko NH. Assessing fluorescence detection and effective photothermal therapy of near-infrared polymer nanoparticles using alginate tissue phantoms. Lasers Surg Med. 2018;50(10):1040–1049.
   PubMed Web of Science ®Google Scholar
• McCabe-Lankford E, Peterson M, McCarthy B, et al. Murine models of intraperitoneal perfusion for disseminated colorectal cancer. J Surg Res. 2019;233:310–322.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Levi-Polyachenko N. Conjugated polymer nano-systems for hyperthermia, imaging and drug delivery. Adv Drug Deliv Rev . 2020;163–164:40–64.
   PubMed Web of Science ®Google Scholar
• Chen H, Shao L, Ming T, et al. Understanding the photothermal conversion efficiency of gold nanocrystals. Small. 2010;6(20):2272–2280.
   PubMed Web of Science ®Google Scholar
• Cole JR, Mirin NA, Knight MW, et al. Photothermal efficiencies of nanoshells and nanorods for clinical therapeutic applications. J Phys Chem C. 2009;113(28):12090–12094.
   Web of Science ®Google Scholar
• Hettinga J, Konings A, Kampinga H. Reduction of cellular cisplatin resistance by hyperthermia-a review. Int J Hyperthermia. 1997;13(5):439–457.
   PubMed Web of Science ®Google Scholar
• Spiliotis J, Halkia E, Lianos E, et al. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol. 2015;22(5):1570–1575.
   PubMed Web of Science ®Google Scholar
• Deraco M, Virzi S, Iusco D, et al. Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study. BJOG. 2012;119(7):800–809.
   PubMed Web of Science ®Google Scholar
• Bakrin N, Cotte E, Golfier F, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients. Ann Surg Oncol. 2012;19(13):4052–4058.
   PubMed Web of Science ®Google Scholar
• Bakrin N, Bereder J-M, Decullier E, et al. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol. 2013;39(12):1435–1443.
   PubMed Web of Science ®Google Scholar
• McCabe-Lankford E, McCarthy B, Berwick MA, et al. Binding of targeted semiconducting photothermal polymer nanoparticles for intraperitoneal detection and treatment of colorectal cancer. Nanotheranostics. 2020;4(3):107–118.
   PubMedGoogle Scholar
• Odéen H, Parker DL. Non‐invasive thermometry with magnetic resonance imaging. Theory Appl Heat Transf Humans. 2018;1:267–299.
   Google Scholar
• Wang X-d, Wolfbeis OS, Meier RJ. Luminescent probes and sensors for temperature. Chem Soc Rev. 2013;42(19):7834–7869.
   PubMed Web of Science ®Google Scholar
• Baffou G, Rigneault H, Marguet D, et al. A critique of methods for temperature imaging in single cells. Nat Methods. 2014;11(9):899–901.
   PubMed Web of Science ®Google Scholar
• Creixell M, Bohorquez AC, Torres-Lugo M, et al. EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. ACS Nano. 2011;5(9):7124–7129.
   PubMed Web of Science ®Google Scholar
• Gremonprez F, Willaert W, Ceelen W. Intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis: review of animal models. J Surg Oncol. 2014;109(2):110–116.
   PubMed Web of Science ®Google Scholar
• Michels AA, Nguyen VT, Konings AW, et al. Thermostability of a nuclear-targeted luciferase expressed in mammalian cells. Destabilizing influence of the intranuclear microenvironment. Eur J Biochem. 1995;234(2):382–389.
   PubMedGoogle Scholar